Omission of or Poor Response to Preoperative Chemoradiotherapy Impacts Radial Margin Positivity Rates in Locally Advanced Rectal Cancer

被引:3
作者
Ore, Ana Sofia [1 ]
Dombek, Gabrielle E. [1 ]
Cordova-Cassia, Carlos A. [1 ]
Quinn, Jeanne F. [1 ]
Cataldo, Thomas E. [1 ]
Schlechter, Benjamin L. [2 ]
Abrams, Matthew J. [3 ]
Messaris, Evangelos [1 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Colorectal Surg, Rectal Canc Program, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Div Hematol & Oncol, Boston, MA 02115 USA
[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Rectal Canc Program, Boston, MA 02115 USA
关键词
Locally advanced rectal cancer; Neoadjuvant chemoradiotherapy; Radial margin; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; TOTAL MESORECTAL EXCISION; NEOADJUVANT CHEMORADIATION; CIRCUMFERENTIAL MARGIN; RESECTION MARGIN; RADIOTHERAPY; MULTICENTER; CARCINOMA; INVOLVEMENT; PATHOLOGIST;
D O I
10.1097/DCR.0000000000001916
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: In the setting of multidisciplinary standardized care of locally advanced rectal cancer, preoperative chemoradiotherapy and total mesorectal excision have become the mainstay treatment. OBJECTIVE: This study aimed to evaluate whether the lack of preoperative chemoradiotherapy or poor response to it is associated with higher radial margin disease involvement in patients with locally advanced rectal cancer. DESIGN: This is a retrospective cohort study using a publicly available database. SETTING: Data were collected from the proctectomy-targeted National Surgical Quality Improvement Project file from 2016 to 2017. PATIENTS: A total of 1161 patients were analyzed. They were categorized into 3 groups: patients who did not receive any preoperative chemoradiotherapy (28.6%), patients who received and responded to preoperative chemoradiotherapy (41.2%), and patients who received but did not respond to preoperative chemoradiotherapy (30.2%). MAIN OUTCOME MEASURES: Response to treatment was determined by using the American Joint Committee on Cancer pretreatment and final pathological staging. Circumferential radial margin was extracted from the targeted proctectomy file. RESULTS: Disease-involved positive circumferential radial margin was found in 86 (7.4%) cases. Positive radial margin was noted in 11 of 479 patients (2.3%) who underwent preoperative chemoradiotherapy and responded to treatment, 30 of 350 patients (8.6%) who did not respond or had a poor response to preoperative chemoradiotherapy, and 45 of 332 patients (13.6%) who did not receive preoperative chemoradiotherapy (p < 0.001). Regression analysis demonstrated that patients who do not receive preoperative chemoradiotherapy or have poor response to it have 6.6 and 4 times higher chances of having a positive radial margin. LIMITATIONS: There is a risk of selection bias, unidentified confounders, and missing data despite the use of a nationwide cohort. CONCLUSIONS: Omission of indicated preoperative chemoradiotherapy or poor response to it is associated with increased risk of radial margin positivity. More efforts are needed for standardized rectal cancer care with the appropriate use of preoperative chemoradiotherapy. See Video Abstract at .
引用
收藏
页码:669 / 676
页数:8
相关论文
共 50 条
  • [41] Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Bedrikovetski, Sergei
    Traeger, Luke
    Vather, Ryash
    Sammour, Tarik
    Moore, James W.
    DISEASES OF THE COLON & RECTUM, 2023, 66 (07) : 965 - 972
  • [42] Relationships Between SMAD3 Expression and Preoperative Fluoropyrimidine-Based Chemoradiotherapy Response in Locally Advanced Rectal Cancer Patients
    Huang, Ming-Yii
    Lin, Chih-Hung
    Huang, Chun-Ming
    Tsai, Hsiang-Lin
    Huang, Ching-Wen
    Yeh, Yung-Sung
    Chai, Chee-Yin
    Wang, Jaw-Yuan
    WORLD JOURNAL OF SURGERY, 2015, 39 (05) : 1257 - 1267
  • [43] Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation
    Bensignor, T.
    Brouquet, A.
    Dariane, C.
    Thirot-Bidault, A.
    Lazure, T.
    Julie, C.
    Nordlinger, B.
    Penna, C.
    Benoist, S.
    COLORECTAL DISEASE, 2015, 17 (06) : 491 - 498
  • [44] Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
    Zhang, Zhaohe
    Jiang, Xiran
    Zhang, Rui
    Yu, Tao
    Liu, Shanshan
    Luo, Yahong
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2021, 27 (03): : 308 - +
  • [45] Is Metformin Associated With Improved Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer?
    Planellas, Pere
    Cornejo, Lidia
    Ignacio Rodriguez-Hermosa, Jose
    Maldonado, Eloy
    Timoteo, Ander
    Hernandez-Yague, Xavier
    Farres, Ramon
    Codina-Cazador, Antoni
    JOURNAL OF SURGICAL RESEARCH, 2021, 268 : 465 - 473
  • [46] Preoperative Treatment of Locally Advanced Rectal Cancer
    Schrag, Deborah
    Shi, Qian
    Weiser, Martin R.
    Gollub, Marc J.
    Saltz, Leonard B.
    Musher, Benjamin L.
    Goldberg, Joel
    Al Baghdadi, Tareq
    Goodman, Karyn A.
    McWilliams, Robert R.
    Farma, Jeffrey M.
    George, Thomas J.
    Kennecke, Hagen F.
    Shergill, Ardaman
    Montemurro, Michael
    Nelson, Garth D.
    Colgrove, Brian
    Gordon, Vallerie
    Venook, Alan P.
    O'Reilly, Eileen M.
    Meyerhardt, Jeffrey A.
    Dueck, Amylou C.
    Basch, Ethan
    Chang, George J.
    Mamon, Harvey J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (04) : 322 - 334
  • [47] Poor nutrition and sarcopenia are related to systemic inflammatory response in patients with rectal cancer undergoing preoperative chemoradiotherapy
    Abe, Shinya
    Nozawa, Hiroaki
    Kawai, Kazushige
    Sasaki, Kazuhito
    Murono, Koji
    Emoto, Shigenobu
    Kishikawa, Junko
    Ozawa, Tsuyoshi
    Yokoyama, Yuichiro
    Nagai, Yuzo
    Anzai, Hiroyuki
    Sonoda, Hirofumi
    Ishihara, Soichiro
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (01) : 189 - 200
  • [48] Annexin and Survivin in Locally Advanced Rectal Cancer: Indicators of Resistance to Preoperative Chemoradiotherapy?
    Horisberger, Karoline
    Erben, Philipp
    Stroebel, Philipp
    Bohn, Beatrice
    Hahn, Melanie
    Kaehler, Georg
    Wenz, Frederik
    Hochhaus, Andreas
    Post, Stefan
    Willeke, Frank
    Hofheinz, Ralf-Dieter
    ONKOLOGIE, 2010, 33 (8-9): : 439 - 444
  • [49] Preoperative Treatment of Locally Advanced Rectal Cancer
    Schrag, Deborah
    Shi, Qian
    Weiser, Martin R.
    Gollub, Marc J.
    Saltz, Leonard B.
    Musher, Benjamin L.
    Goldberg, Joel
    Al Baghdadi, Tareq
    Goodman, Karyn A.
    McWilliams, Robert R.
    Farma, Jeffrey M.
    George, Thomas J.
    Kennecke, Hagen F.
    Shergill, Ardaman
    Montemurro, Michael
    Nelson, Garth D.
    Colgrove, Brian
    Gordon, Vallerie
    Venook, Alan P.
    O'Reilly, Eileen M.
    Meyerhardt, Jeffrey A.
    Dueck, Amylou C.
    Basch, Ethan
    Chang, George J.
    Mamon, Harvey J.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (08): : 701 - 701
  • [50] Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom?
    De Stefano, Alfonso
    Moretto, Roberto
    Bucci, Luigi
    Pepe, Stefano
    Romano, Francesco Jacopo
    Cella, Alessandra Chiara
    Attademo, Laura
    Rosanova, Mario
    De Falco, Stefano
    Fiore, Giovanni
    Raimondo, Lucia
    De Placido, Sabino
    Carlomagno, Chiara
    CLINICAL COLORECTAL CANCER, 2014, 13 (03) : 185 - 191